Literature DB >> 28304129

Development of Shiny app tools to simplify and standardize the analysis of hemostasis assay data: communication from the SSC of the ISTH.

C Longstaff1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28304129     DOI： 10.1111/jth.13656

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  17 in total

1.  Tranexamic acid is an active site inhibitor of urokinase plasminogen activator.

Authors:  Guojie Wu; Blake A Mazzitelli; Adam J Quek; Matthew J Veldman; Paul J Conroy; Tom T Caradoc-Davies; Lisa M Ooms; Kellie L Tuck; Jonathan G Schoenecker; James C Whisstock; Ruby H P Law
Journal:  Blood Adv       Date:  2019-03-12

2.  Extracellular Histones Inhibit Fibrinolysis through Noncovalent and Covalent Interactions with Fibrin.

Authors:  Matthew Locke; Colin Longstaff
Journal:  Thromb Haemost       Date:  2020-11-01       Impact factor: 5.249

3.  3K3A-Activated Protein C Variant Does Not Interfere With the Plasma Clot Lysis Activity of Tenecteplase.

Authors:  Purba Mukherjee; Patrick Lyden; José A Fernández; Thomas P Davis; Kent E Pryor; Berislav V Zlokovic; John H Griffin
Journal:  Stroke       Date:  2020-06-17       Impact factor: 7.914

4.  Thrombin generation and fibrin clot structure after vitamin D supplementation.

Authors:  Marc Blondon; Emmanuel Biver; Olivia Braillard; Marc Righini; Pierre Fontana; Alessandro Casini
Journal:  Endocr Connect       Date:  2019-11-01       Impact factor: 3.335

5.  Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.

Authors:  Anton Ilich; Vaibhav Kumar; Michael J Ferrara; Michael W Henderson; Denis F Noubouossie; Donald H Jenkins; Rosemary A Kozar; Myung S Park; Nigel S Key
Journal:  Thromb Res       Date:  2021-05-31       Impact factor: 10.407

Review 6.  Measuring fibrinolysis: from research to routine diagnostic assays.

Authors:  C Longstaff
Journal:  J Thromb Haemost       Date:  2018-02-17       Impact factor: 5.824

7.  Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From Staphylococcus aureus.

Authors:  Ádám Z Farkas; Veronika J Farkas; László Szabó; András Wacha; Attila Bóta; Lóránt Csehi; Krasimir Kolev; Craig Thelwell
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

8.  A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis.

Authors:  Rita Orbán-Kálmándi; István Szegedi; Ferenc Sarkady; István Fekete; Klára Fekete; Nikolett Vasas; Ervin Berényi; László Csiba; Zsuzsa Bagoly
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

9.  Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay.

Authors:  C Longstaff; M Locke
Journal:  J Thromb Haemost       Date:  2018-12-13       Impact factor: 5.824

10.  Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial.

Authors:  Suzanne Schol-Gelok; Moniek P M de Maat; Joseph S Biedermann; Teun van Gelder; Frank W G Leebeek; Willem M Lijfering; Felix J M van der Meer; Dingeman C Rijken; Jorie Versmissen; Marieke J H A Kruip
Journal:  Br J Haematol       Date:  2020-04-16       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.